- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 06.10. | Lilly deepens ties with Gate Bioscience in $870m deal expansion | ||
| 06.10. | Alector shares up after sealing $1.27bn Roche Parkinson's disease license deal | ||
| 06.10. | CSL and Alentis ink $1.5bn partnership to progress antifibrotic drug | ||
| 06.10. | Pacira partners with Molteni for Exparel commercialisation | ||
| 06.10. | AstraZeneca opens new R&D centre in Cambridge, US | ||
| 05.10. | Scientists claim Nobel Prize for approach behind light-activated gene therapy | ||
| 05.10. | FDA approves expanded indication for Lilly's Jaypirca | ||
| 05.10. | Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US | ||
| 02.10. | AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact | ||
| 01.10. | Varda pockets $251m to back space-based pharma processing mission | ||
| 01.10. | Sanofi and Regeneron expand immunology partnership to the tune of $8bn | ||
| 01.10. | Bristol Myers Squibb secures expanded US approval for Camzyos | ||
| 01.10. | BioMarin and Profluent partner on AI-designed enzyme therapies | ||
| 30.09. | Atossa plans shareholder stake in potential PRV proceeds | ||
| 30.09. | OBIO marks $704m funding milestone for Canadian health tech ventures | ||
| 30.09. | Kyowa Kirin, Knight agree Latin American distribution deal for mogamulizumab | ||
| 29.09. | Novo outlays $2.6bn in Hengrui deal to bolster oral obesity pipeline | ||
| 29.09. | MSD bets $2.13bn on SciBrunch's KRAS (ON) inhibitor | ||
| 29.09. | AstraZeneca to invest $2bn in Summit for ADC combination therapies | ||
| 29.09. | Tolerance Bio signs $560m worldwide TLB-33 deal with Tanabe Pharma | ||
| 28.09. | AbbVie lands FDA approval for next-generation Parkinson's drug, Juvmo | ||
| 28.09. | Novo inks $1.33bn long-lasting injectable pact with Sweden-based Nanexa | ||
| 28.09. | Daiichi Sankyo, MSD withdraw cancer drug application | ||
| 28.09. | Mirum and Incyte's Atebrioz approved for FOP in US | ||
| 25.09. | Aptar Pharma and Macquarie University partner on drug delivery project |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.